BioInvent International AB (BINV) — Defensive Interval Ratio
BioInvent International AB (BINV) has a Defensive Interval Ratio of 1654 days as of June 2025. Defensive assets of Skr462.77 Million (cash Skr-, short-term investments Skr393.47 Million, receivables Skr69.30 Million) cover 1654 days of daily cash needs of Skr279.76K/day. Check BioInvent International AB tangible book value ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BioInvent International AB Defensive Interval Ratio (2000–2024)
This chart shows how BioInvent International AB's Defensive Interval Ratio has evolved across 25 annual periods from 2000 to 2024. As of June 2025, the ratio stands at 1654 days, meaning defensive assets of Skr462.77 Million can fund 1654 days of operations without new revenue. Also explore BioInvent International AB (BINV) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for BioInvent International AB (2000–2024)
The table below presents the year-by-year Defensive Interval Ratio for BioInvent International AB from 2000 to 2024, covering 25 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BioInvent International AB market capitalisation.
| Year | DIR (days) | Defensive Assets (SEK) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 1777 days | Skr463.58 Million | Skr260.84K/day | Skr- | Skr432.33 Million | ▼ -2170 days |
| 2023 | 3948 days | Skr821.08 Million | Skr207.99K/day | Skr- | Skr809.15 Million | ▲ +1695 days |
| 2022 | 2253 days | Skr539.01 Million | Skr239.23K/day | Skr- | Skr502.43 Million | ▲ +1126 days |
| 2021 | 1127 days | Skr181.47 Million | Skr161.07K/day | Skr- | Skr172.07 Million | ▲ +885 days |
| 2020 | 242 days | Skr35.47 Million | Skr146.60K/day | Skr- | Skr- | ▲ +11 days |
| 2019 | 231 days | Skr29.85 Million | Skr129.32K/day | Skr- | Skr- | ▼ -35 days |
| 2018 | 266 days | Skr23.91 Million | Skr89.81K/day | Skr- | Skr- | ▼ -91 days |
| 2017 | 357 days | Skr38.93 Million | Skr109.10K/day | Skr- | Skr30.06 Million | ▲ +102 days |
| 2016 | 255 days | Skr32.06 Million | Skr125.65K/day | Skr- | Skr- | ▲ +126 days |
| 2015 | 129 days | Skr8.86 Million | Skr68.47K/day | Skr- | Skr- | ▼ -774 days |
| 2014 | 904 days | Skr53.67 Million | Skr59.40K/day | Skr- | Skr37.03 Million | ▲ +243 days |
| 2013 | 661 days | Skr58.72 Million | Skr88.85K/day | Skr- | Skr50.07 Million | ▲ +221 days |
| 2012 | 440 days | Skr83.07 Million | Skr188.82K/day | Skr- | Skr79.34 Million | ▼ -66 days |
| 2011 | 506 days | Skr93.98 Million | Skr185.77K/day | Skr- | Skr81.62 Million | ▲ +41 days |
| 2010 | 464 days | Skr81.23 Million | Skr174.90K/day | Skr- | Skr69.12 Million | ▲ +336 days |
| 2009 | 128 days | Skr24.80 Million | Skr193.46K/day | Skr- | Skr9.98 Million | ▼ -746 days |
| 2008 | 874 days | Skr153.52 Million | Skr175.70K/day | Skr- | Skr161.18 Million | ▼ -241 days |
| 2007 | 1115 days | Skr173.80 Million | Skr155.84K/day | Skr- | Skr154.37 Million | ▲ +54 days |
| 2006 | 1061 days | Skr110.98 Million | Skr104.60K/day | Skr- | Skr19.96 Million | ▲ +451 days |
| 2005 | 610 days | Skr79.12 Million | Skr129.71K/day | Skr- | Skr59.78 Million | ▲ +432 days |
| 2004 | 178 days | Skr12.57 Million | Skr70.48K/day | Skr- | Skr- | ▲ +122 days |
| 2003 | 57 days | Skr5.94 Million | Skr104.73K/day | Skr- | Skr- | ▼ -49 days |
| 2002 | 106 days | Skr15.12 Million | Skr142.90K/day | Skr- | Skr- | ▼ -263 days |
| 2001 | 369 days | Skr22.39 Million | Skr60.64K/day | Skr- | Skr- | ▲ +95 days |
| 2000 | 274 days | Skr26.02 Million | Skr94.86K/day | Skr- | Skr10.23 Million | — |